Evaluation of vinorelbine in persistent or recurrent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study

Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients.

Thierry Le Chevalier, D. Brisgand, Jean‐Yves Douillard et al. · Journal of Clinical Oncology · 1994 · 824 citations

Medicine, Oncology, Pharmacology +12

Randomized trial of three cisplatin dose schedules in squamous-cell carcinoma of the cervix: a Gynecologic Oncology Group study.

Philip Bonomi, John A. Blessing, Frederick B. Stehman et al. · Journal of Clinical Oncology · 1985 · 406 citations

Medicine, Oncology, Pharmacotherapy +15

Cis-platinum in treatment of advanced or recurrent squamous cell carcinoma of the cervix: A phase ii study of the gynecologic oncology group

Tate Thigpen, Hugh M. Shingleton, Howard D. Homesley et al. · Cancer · 1981 · 294 citations

Medicine, Gynecology, Oncology +17

Randomized trial of cisplatin versus cisplatin plus mitolactol versus cisplatin plus ifosfamide in advanced squamous carcinoma of the cervix: a Gynecologic Oncology Group study.

G Omura, J A Blessing, Luis Vaccarello et al. · Journal of Clinical Oncology · 1997 · 275 citations

Medicine, Oncology, Pharmacology +11

Paclitaxel has moderate activity in squamous cervix cancer. A Gynecologic Oncology Group study.

William P. McGuire, John A. Blessing, David H. Moore et al. · Journal of Clinical Oncology · 1996 · 222 citations

Medicine, Oncology, Pharmacology +11